These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 38222457)

  • 1. Timolol maleate, a β blocker eye drop, improved edema in a retinal vein occlusion model.
    Fuma S; Hidaka Y; Nishinaka A; Yasuda H; Aoshima K; Nakamura S; Hara H; Shimazawa M
    Mol Vis; 2023; 29():188-196. PubMed ID: 38222457
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of ripasudil, a ROCK inhibitor, on retinal edema and nonperfusion area in a retinal vein occlusion murine model.
    Hida Y; Nakamura S; Nishinaka A; Inoue Y; Shimazawa M; Hara H
    J Pharmacol Sci; 2018 Jun; 137(2):129-136. PubMed ID: 29983234
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral and ocular administration of crocetin prevents retinal edema in a murine retinal vein occlusion model.
    Nitta K; Nishinaka A; Hida Y; Nakamura S; Shimazawa M; Hara H
    Mol Vis; 2019; 25():859-868. PubMed ID: 31908404
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Creation of Retinal Vein Occlusion Model in Cynomolgus Monkeys and Determination of its Pathological Features.
    Inagaki S; Shimazawa M; Otsu W; Araki T; Numata Y; Nakamura S; Tsusaki H; Hara H
    Curr Neurovasc Res; 2021; 18(1):123-133. PubMed ID: 32867658
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TOPICAL DORZOLAMIDE-TIMOLOL WITH INTRAVITREOUS ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR FOR RETINAL VEIN OCCLUSION: A PILOT STUDY.
    Obeid A; Hsu J; Ehmann D; Gao X; Sridhar J; Chiang A; Park CH; Ho AC
    Retin Cases Brief Rep; 2021 Mar; 15(2):120-126. PubMed ID: 29864044
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Arctigenin Prevents Retinal Edema in a Murine Retinal Vein Occlusion Model.
    Hidaka Y; Nakamura S; Nishinaka A; Takajo Y; Inamasu S; Yomoda S; Shimazawa M; Hara H
    Biol Pharm Bull; 2023; 46(3):473-481. PubMed ID: 36858576
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ocular hypotensive effects and safety over 3 months of switching from an unfixed combination to latanoprost 0.005%/timolol maleate 0.5% fixed combination.
    Inoue K; Okayama R; Higa R; Sawada H; Wakakura M; Tomita G
    J Ocul Pharmacol Ther; 2011 Dec; 27(6):581-7. PubMed ID: 22011049
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of kallidinogenase on retinal edema and size of non-perfused areas in mice with retinal vein occlusion.
    Nishinaka A; Fuma S; Inoue Y; Shimazawa M; Hara H
    J Pharmacol Sci; 2017 Jun; 134(2):86-92. PubMed ID: 28619445
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The anti-inflammatory and anti-oxidative effects of conbercept in treatment of macular edema secondary to retinal vein occlusion.
    Xia JP; Wang S; Zhang JS
    Biochem Biophys Res Commun; 2019 Jan; 508(4):1264-1270. PubMed ID: 30558792
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral administration of NSP-116, a free radical scavenger, suppresses the symptoms of retinal vein occlusion in the murine model.
    Yamamoto T; Nitta K; Nishinaka A; Tanaka M; Nakamura S; Shimazawa M; Hara H
    Exp Eye Res; 2021 Mar; 204():108453. PubMed ID: 33503450
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathophysiological Role of VEGF on Retinal Edema and Nonperfused Areas in Mouse Eyes With Retinal Vein Occlusion.
    Nishinaka A; Inoue Y; Fuma S; Hida Y; Nakamura S; Shimazawa M; Hara H
    Invest Ophthalmol Vis Sci; 2018 Sep; 59(11):4701-4713. PubMed ID: 30267092
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vitreal levels of erythropoietin are increased in patients with retinal vein occlusion and correlate with vitreal VEGF and the extent of macular edema.
    Stahl A; Buchwald A; Martin G; Junker B; Chen J; Hansen LL; Agostini HT; Smith LE; Feltgen N
    Retina; 2010 Oct; 30(9):1524-9. PubMed ID: 20664492
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Changes of Irisin and Inflammatory Cytokines in the Age-Related Macular Degeneration and Retinal Vein Occlusion.
    Li X; Cao X; Zhao M; Bao Y
    Front Endocrinol (Lausanne); 2022; 13():861757. PubMed ID: 35370941
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TRPV4 channels promote vascular permeability in retinal vascular disease.
    Nishinaka A; Tanaka M; Ohara K; Sugaru E; Shishido Y; Sugiura A; Moriguchi Y; Toui A; Nakamura S; Shimada K; Watanabe S; Hara H; Shimazawa M
    Exp Eye Res; 2023 Mar; 228():109405. PubMed ID: 36773739
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alteration of plasma von Willebrand factor in the treatment of retinal vein occlusion with cystoid macular edema.
    Hirai H; Yamashita M; Matsumoto M; Nishiyama T; Wada D; Okabe N; Mizusawa Y; Jimura H; Ueda T; Ogata N
    PLoS One; 2022; 17(9):e0264809. PubMed ID: 36137144
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Photocoagulation of the Retinal Nonperfusion Area Prevents the Expression of the Vascular Endothelial Growth Factor in an Animal Model.
    Gozawa M; Takamura Y; Miyake S; Matsumura T; Morioka M; Yamada Y; Inatani M
    Invest Ophthalmol Vis Sci; 2017 Nov; 58(13):5946-5953. PubMed ID: 29098298
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The protective effect of anti-VEGF-A/Ang-2 bispecific antibody on retinal vein occlusion model mice.
    Kuriyama A; Nakamura S; Inokuchi Y; Abe H; Yasuda H; Hidaka Y; Nagaoka K; Soeda T; Shimazawa M; Hara H
    Eur J Pharmacol; 2024 Aug; 976():176691. PubMed ID: 38821166
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Timolol + latanoprost: new preparation. Last-resort eye drops.
    Prescrire Int; 2003 Oct; 12(67):173-4. PubMed ID: 14619889
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes of vascular endothelial growth factor after vitrectomy for macular edema secondary to retinal vein occlusion.
    Noma H; Funatsu H; Mimura T; Hori S
    Eur J Ophthalmol; 2008; 18(6):1017-9. PubMed ID: 18988180
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Role of Serum Inflammation-Based Factors in Anti-Vascular Endothelial Growth Factor Treatment for Macular Edema Secondary to Retinal Vein Occlusion and Its Subtypes.
    Rao J; Wu N; Qu X; Hu Y; Wu Y; Cheng Y; Yan L; Huang H; Li S; Shi L; Wu X
    Ophthalmic Res; 2021; 64(2):237-245. PubMed ID: 32506058
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.